Citigroup analyst Neena Bitritto-Garg maintains Amylyx Pharma (NASDAQ:AMLX) with a Buy and raises the price target from $33 to $37.
Arlo Technologies Q4 Adj. EPS $(0.04) Beats $(0.10) Estimate, Sales $118.50M Beat $107.44M Estimate
Arlo Technologies (NYSE:ARLO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.10) by 60 percent. This is a 200 percent decrease over earnings of $0.04 per share from the
